There are currently 40 active clinical trials seeking participants for Cognitive Decline research studies. The states with the highest number of trials for Autism participants are Illinois, Michigan, Minnesota and Ohio.
Time Restricted Eating Plus Exercise for Weight Management
Recruiting
Time restricted eating (TRE) is currently the most popular form of intermittent fasting which involves confining the eating window to 8-10 hours (h) and fasting for the remaining hours of the day. TRE is unique in that during the eating window, individuals are not required to count calories or monitor food intake in any way, resulting in high adherence. Accumulating evidence suggests that TRE produces a natural energy deficit of ~350-500 kcal/d. Physical activity in combination with a healthy di... Read More
Gender:
All
Ages:
Between 60 years and 75 years
Trial Updated:
11/17/2023
Locations: University of Illinois at Chicago, Chicago, Illinois
Conditions: Intermittent Fasting, Pre Diabetes, Cognitive Decline
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Recruiting
The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/14/2023
Locations: Parkview Cancer Institute, Fort Wayne, Indiana
Conditions: Neoplasm, Colorectal, Cognitive Impairment, Cognitive Dysfunction, Cognitive Change, Chemo-brain, Chemo Fog, Chemotherapy Effect, Cognitive Decline
Brain Health Virtual Reality Study
Recruiting
The Interventions for Brain Health Virtual Reality Study is a NIH-funded clinical research trial at the University of California San Diego (UCSD) Health under the supervision of the study principal investigator Dr. Judy Pa. The overarching goal of this trial is to use a novel virtual reality (VR) based intervention that simultaneously engages physical and cognitive activity aimed at improving brain health and cognition in older adults. The investigators will compare 3 types of interventions: phy... Read More
Gender:
All
Ages:
Between 50 years and 85 years
Trial Updated:
11/03/2023
Locations: University of California, San Diego, San Diego, California
Conditions: Aging, Aging Problems, Memory Loss, Memory Impairment, Memory Disorders in Old Age, Memory Disorder, Spatial, Memory Disorders, Mild Cognitive Impairment, Cognitive Decline, Cognitive Change, Cognition Disorders in Old Age
Preventing Cognitive Decline by Reducing BP Target Trial
Recruiting
The PCOT study is a multi-site randomized trial of patients 70 years or older with high BP. The main goal of the study Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) is to conduct a large pragmatic clinical trial (PCT) to test the hypothesis that patients who receive care with a combination of clinical decision support (CDS) and team-based care delivered in primary care practices will have better blood pressure control and a lower incidence of mild cognitive impairment and demen... Read More
Gender:
All
Ages:
70 years and above
Trial Updated:
10/27/2023
Locations: UT Southwestern Medical Center, Dallas, Texas
Conditions: Cognitive Decline, Blood Pressure, Hypertension
Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults
Recruiting
This study will test whether consuming blueberry powder 20g/d for 24 weeks can improve memory and other cognitive function and alter serum biomarkers of brain injury among older adults.
Gender:
All
Ages:
Between 65 years and 99 years
Trial Updated:
10/24/2023
Locations: Mass General Brigham, Boston, Massachusetts
Conditions: Cognitive Decline, Nutrition, Healthy, Brain Injuries
Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
Recruiting
The goal of this prospective cohort study is to assess potential differences in sleep biomarkers in older adult patients undergoing major orthopedic surgery. The main questions it aims to answer are: To define sleep/circadian biomarkers of delirium (sleep duration, regularity, stability and timing of rhythm) in a prospective observational study. To determine if plasma Alzheimer's disease (AD) pathology/inflammatory burden interacts with or moderates the relationship between a sleep/circadian bi... Read More
Gender:
All
Ages:
70 years and above
Trial Updated:
10/20/2023
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Delirium, Postoperative, Cognitive Decline, Dementia
Endoprosthesis Metal Toxicity Study
Recruiting
The purpose of this research is to investigate whether patients who previously had endoprosthesis surgery experience memory, thinking, or heart problems. It will also help determine how often these problems occur.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
07/18/2023
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Bone Tumor, Cancer of Bone, Heart Diseases, Cognitive Impairment, Cognitive Decline, Chemotherapy Effect, Memory Problem
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Recruiting
Every year, approximately 9,000 Parkinson disease (PD) patients undergo deep brain stimulator (DBS) placement into the subthalamic nucleus (STN-DBS). Studies suggest that PD patients with mutations in the glucocerebrosidase (GBA) gene are at high risk for cognitive impairment and approximately 10-17% of subjects undergoing DBS carry GBA mutations. There may be an interaction between STN-DBS, which also impairs cognitive function, and GBA, resulting in worsened cognitive function. This project wi... Read More
Gender:
All
Ages:
Between 30 years and 75 years
Trial Updated:
06/01/2023
Locations: Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey
Conditions: Parkinson, Parkinson Disease, Genetic Predisposition, GBA Gene Mutation, Cognitive Decline
Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline
Recruiting
The proposed study will test a multifaceted strategy for implementing an intensive blood pressure intervention protocol targeting systolic BP <120 mmHg on cognitive decline in racial minority and low-income hypertensive patients in primary care. The proposed study will generate urgently needed data on effective, adoptable, and equitable intervention strategies to reduce blood pressure-related cognitive decline in low- income and minority populations. If proven effective, the implementation strat... Read More
Gender:
All
Ages:
40 years and above
Trial Updated:
05/15/2023
Locations: Tulane University, New Orleans, Louisiana
Conditions: Hypertension, Cognitive Decline
Glucose Variability and Cognition in Prediabetes
Recruiting
This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
Gender:
All
Ages:
50 years and above
Trial Updated:
05/15/2023
Locations: Baltimore VA Geriatric Research Education and Clinical Center (GRECC), Baltimore, Maryland
Conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus), Cognitive Decline, Functional Status, PreDiabetes, Aging, Depression
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
Recruiting
The investigators will study performance on computerized cognitive tasks in healthy participants of different ages to gather normative data for newly developed computerized cognitive tests. These tests are designed to permit the early detection of individuals at risk of age-related cognitive decline.
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
03/22/2023
Locations: Neurobehavioral Systems, Inc., Berkeley, California
Conditions: Alzheimer Disease, Aging, Cognitive Decline
Older Breast Cancer Patients: Risk for Cognitive Decline
Recruiting
The goal of this study is to evaluate the impact of systemic therapy on cognition in older breast cancer patients, explore change in APE, LM and Cognition domains, measure associations between cognitive decline and QOL, and describe how genetic polymorphisms, inflammatory biomarkers, sleep and physical measures moderate cognitive outcomes. This study is being done nationally, with recruiting sites at Georgetown University, Montgomery General Hospital, Virginia Cancer Specialists, Washington Hosp... Read More
Gender:
Female
Ages:
Between 60 years and 105 years
Trial Updated:
03/09/2023
Locations: Georgetown University, Washington, District of Columbia
Conditions: Cancer, Breast, Age-related Cognitive Decline, Cognitive Decline